Granulocyte-macrophage colony-stimulating factor (GM-CSF) neutralizing antibodies
US8609101B2 · kind B2 · utility
1Cited by
66References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 23, 2010 |
| Grant date | Dec 17, 2013 |
| Priority date | — |
| Expiry date | Feb 2, 2031 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a GM-CSF neutralizing human monoclonal antibody, 1783J22, as well as methods of making and use thereof. The monoclonal antibody is further characterized by its ability to bind epitopes from GM-CSF proteins of multiple species.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.